Neil Seif, MD
Radiation Oncology · Munster, INNPI 1316077662
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $526 and has fallen 95.5% since, to $24 in 2025.
Across 49 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$176
- Merck$151
- Genentech USA, Inc.$90
- Bayer$65
- Seagen Inc.$64
- Bristol Myers Squibb$51
- plus $324 from 15 others
What the payments were for
- Food & beverage$921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $176 |
| Merck | 8 | $151 |
| Genentech USA, Inc. | 4 | $90 |
| Bayer | 3 | $65 |
| Seagen Inc. | 4 | $64 |
| Bristol Myers Squibb | 3 | $51 |
| Exelixis Inc. | 2 | $30 |
| Medtronic | 1 | $26 |
| Lantheus Medical Imaging, Inc. | 2 | $25 |
| Novartis | 1 | $25 |
| Boston Scientific | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Sanofi | 1 | $17 |
| Epizyme, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$921 in reported general payments places this provider in the 55th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Munster
- Maria AguirreMunster$3K
- Virag DandekarMunster$660
- Brian ChangFort Wayne$13K
- Michael EatonIndianapolis$11K
- William PorterMadison$8K
- Binh TranMishawaka$7K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Houman VaghefiGoshen$5K
- Peter GarrettIndianapolis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.